Results 211 to 220 of about 22,974 (229)

Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres

Journal of Controlled Release, 2017
Jie Shen, Yuan Zou
exaly  

Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate

Addiction, 2018
Clément Palpacuer, Clara Locher, Florian Naudet   +2 more
exaly  

Naltrexone

Reactions Weekly, 2002
openaire   +1 more source

A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients

Neuropsychopharmacology, 2003
David W Oslin, Henry Kranzler, Joel Gelernter   +2 more
exaly  

Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine

American Journal of Psychiatry, 2017
Maria A Sullivan, Adam Bisaga, Martina Pavlicova   +2 more
exaly  

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

American Journal of Psychiatry, 2019
Maria A Sullivan, , Martina Pavlicova
exaly  

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

Addiction, 2004
Carmen Bouza
exaly  

Naltrexone

Reactions Weekly, 2015
openaire   +2 more sources

Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4)

European Journal of Neuroscience, 2008
Mark R. Hutchinson, Kenner C Rice
exaly  

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Drug and Alcohol Dependence, 2019
Jake R Morgan, Bruce R Schackman, Zoe M Weinstein   +2 more
exaly